S Alamelu, KB Venkatesan, K Shagirtha… - Drugs and Drug …, 2024 - mdpi.com
Breast cancer (BC) is the most prevalent form of malignancy among women on a global scale, ranking alongside lung cancer. Presently, conventional approaches to cancer …
W Zhang, Y Xu, R Guo, P Zhuang, H Hong, H Tan… - ACS …, 2024 - ACS Publications
Designing an efficient nanocarrier to target multiple types of cancer remains a major challenge in the development of cancer nanomedicines. The majority of systemically …
Y Sakamoto, S Fujii, S Takano, J Fukushima… - Nano Letters, 2024 - ACS Publications
Nanostructures of drug carriers play a crucial role in nanomedicine due to their ability to influence drug delivery. There is yet no clear consensus regarding the optimal size and …
R Wang, H Liu, B Antal, HT Wolterbeek… - ACS Applied Bio …, 2024 - ACS Publications
The relatively high linear energy transfer of Auger electrons, which can cause clustered DNA damage and hence efficient cell death, makes Auger emitters excellent candidates for …
J Zhao, W Song, Z Wang, T Zhou… - Organic Preparations and …, 2024 - Taylor & Francis
Since its first report in 2007, 1 crystallization-driven self-assembly (CDSA) of coil-crystalline block copolymers (BCPs) in solution has become a prominent branch of polymer self …
Cellulose nanocrystals (CNCs) are biocompatible, non-toxic nanoparticles with many surface hydroxyl functionalities available for chemical modification. In this thesis, I describe …
The development of nanoparticles as drug delivery systems has greatly improved prospects of more selective and safer drug delivery to tumours, by conferring enhanced …
In recent decades, a variety of nanoparticle drug delivery systems (NP DDS)–nanometer- scaled materials physically or covalently interacting with therapeutics–has been developed …